Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:704-709
Published online before print January 20, 2005, doi: 10.1161/01.ATV.0000156399.12787.5c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/4/704    most recent
01.ATV.0000156399.12787.5cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grgic, I.
Right arrow Articles by Köhler, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grgic, I.
Right arrow Articles by Köhler, R.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:704.)
© 2005 American Heart Association, Inc.


Vascular Biology

Selective Blockade of the Intermediate-Conductance Ca2+-Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells and Angiogenesis In Vivo

Ivica Grgic; Ines Eichler; Philipp Heinau; Han Si; Susanne Brakemeier; Joachim Hoyer; Ralf Köhler

From the Department of Nephrology (I.E., S.B.), Charité, Campus Benjamin Franklin, Berlin, and the Department of Internal Medicine-Nephrology (I.G., P.H., H.S., J.H., R.K.), Philipps-University, Marburg, Germany.

Correspondence to Ralf Köhler, Department of Internal Medicine-Nephrology, Philipps-University, Baldingerstrasse, 35033 Marburg, Germany. E-mail rkoehler{at}med.uni-marburg.de

Objective— Ca2+-activated K+ (KCa) channels have been proposed to promote mitogenesis in several cell types. Here, we tested whether the intermediate-conductance KCa channel (IKCa1) and the large-conductance KCa channel (BKCa) contribute to endothelial cell (EC) proliferation and angiogenesis.

Material and Results— Function and expression of IKCa1 and BKCa/Slo were investigated by patch-clamp analysis and real-time RT-PCR in human umbilical vein ECs (HUVECs) and in dermal human microvascular ECs 1 (HMEC-1). HMEC-1 expressed IKCa1 and BKCa/Slo, whereas HUVECs expressed IKCa1. A 48-hour exposure to basic fibroblast growth factor (bFGF) augmented IKCa1 current amplitudes and induced a 3-fold increase in IKCa1 mRNA expression in HUVECs and HMEC-1. Vascular endothelial growth factor (VEGF) was also effective in upregulating IKCa1. BKCa/Slo expression and current amplitudes in HMEC-1 were not altered by bFGF. bFGF- and VEGF-induced EC proliferation was suppressed by charybdotoxin, clotrimazole, or the selective IKCa1 blocker 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34), whereas inhibition of BKCa/Slo by iberiotoxin was ineffective. In the Matrigel plug assay in mice, administration of TRAM-34 for 2 weeks significantly suppressed angiogenesis by {approx}85%.

Conclusions— bFGF and VEGF upregulate expression of IKCa1 in human ECs. This upregulation of IKCa1 seems to be required for mitogen-induced EC proliferation and angiogenesis in vivo. Selective IKCa1 blocker might be of therapeutic value to prevent tumor angiogenesis.

We tested whether Ca2+-activated K+ (KCa) channels contribute to endothelial cell (EC) proliferation induced by proangiogenic factors. Angiogenic factors augmented mRNA expression and function of intermediate-conductance KCa channel (IKCa1). EC proliferation in vitro and angiogenesis in vivo was abolished by IKCa1 blockers, which might be of therapeutic value to prevent tumor angiogenesis.


Key Words: IKCa1 • endothelium • clotrimazole • TRAM-34 • bFGF • angiogenesis




This article has been cited by other articles:


Home page
Stem CellsHome page
G. Kasper, N. Dankert, J. Tuischer, M. Hoeft, T. Gaber, J. D. Glaeser, D. Zander, M. Tschirschmann, M. Thompson, G. Matziolis, et al.
Mesenchymal Stem Cells Regulate Angiogenesis According to Their Mechanical Environment
Stem Cells, April 1, 2007; 25(4): 903 - 910.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. Kaushal, P. D. Koeberle, Y. Wang, and L. C. Schlichter
The Ca2+-Activated K+ Channel KCNN4/KCa3.1 Contributes to Microglia Activation and Nitric Oxide-Dependent Neurodegeneration
J. Neurosci., January 3, 2007; 27(1): 234 - 244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. L. Tharp, B. R. Wamhoff, J. R. Turk, and D. K. Bowles
Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2493 - H2503.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G Cruse, S M Duffy, C E Brightling, and P Bradding
Functional KCa3.1 K+ channels are required for human lung mast cell migration
Thorax, October 1, 2006; 61(10): 880 - 885.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H.-W. Cheng, A.F. James, R.R. Foster, J.C. Hancox, and D.O. Bates
VEGF Activates Receptor-Operated Cation Channels in Human Microvascular Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1768 - 1776.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
J. Ledoux, M. E. Werner, J. E. Brayden, and M. T. Nelson
Calcium-Activated Potassium Channels and the Regulation of Vascular Tone
Physiology, February 1, 2006; 21(1): 69 - 78.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
J. Thompson and T. Begenisich
Membrane-delimited Inhibition of Maxi-K Channel Activity by the Intermediate Conductance Ca2+-activated K Channel
J. Gen. Physiol., January 30, 2006; 127(2): 159 - 169.
[Abstract] [Full Text] [PDF]